The growth is propelled by increases in research and development spending to find new drugs and therapies to treat chronic diseases.

In 2020, project and data management services made up the largest spending share due to the growing requirement of data management and workflow for clinical trial imaging. Operational imaging services, including magnetic resonance imaging, computed tomography (CT), and ultrasound, also held a significant share in 2020. CT, specifically, has gained in popularity due to its noninvasive nature and its ability to provide detailed information about diseases for enhanced treatment, according to the report.

Researchers innovate drug discovery screening techniques
Researchers from around the globe gathered to discuss innovations in laboratory techniques such as phenotypic profiling and flow cytometry for drug discovery...

Preclinical lung imaging offers effective evaluation of drug candidates
Drug discovery and development are arduous and costly endeavors, with nine in 10 drug candidates failing to gain approval. Preclinical imaging can help...